Marketing: Page 88
-
With new facility, Merck bets on China as a market for growth
The company’s new Chinese manufacturing facility, scheduled to open in August, will soon be Merck’s second largest manufacturing facility worldwide.
By Nicole Gray • July 24, 2014 -
Gilead enters the cancer drug arena as FDA approves Zydelig
Zydelig (idelalisib) has been approved by the FDA to treat certain blood cancers.
By Nicole Gray • July 24, 2014 -
Explore the Trendline➔
Brian Tucker / BioPharma Dive/BioPharma Dive
TrendlineCommercialization
New drugs for obesity and Alzheimer’s look set to become blockbusters, reshaping pharma marketing strategies just as many current top-sellers near looming patent cliffs.
By BioPharma Dive staff -
FDA approves extended-release pain pill with built-in abuse deterrent
Targiniq ER is the second FDA-approved painkiller with abuse-deterrent properties. It contains naloxone right in the pill.
By Nicole Gray • July 24, 2014 -
Durata's landmark Qualified Infectious Disease Product launches in U.S.
Durata Therapeutics' Dalvance is the first-ever Qualified Infectious Disease Product drug approved by the FDA.
By Nicole Gray • July 23, 2014 -
Could evolocumab become the gold-standard in cholesterol reduction?
Many in the clinical community say ‘yes’ based on extensive data published in NEJM.
By Nicole Gray • July 23, 2014 -
Lannett inks exclusive deal to distribute ACEON generic in the U.S.
Lannett will be the exclusive American distributor for a generic version of Symplmed Pharmaceuticals' hypertension drug ACEON.
By Nicole Gray • July 22, 2014 -
Allergan hopes to stave off Valeant with Q2 growth, cost-cutting
The company is focused on cost-savings, business development and increasing shareholder value.
By Nicole Gray • July 22, 2014 -
Deep Dive
Niacin: the poster child for post-marketing drug surveillance
More than ever, long-term post-marketing surveillance matters.
By Nicole Gray • July 21, 2014 -
Could Gilead's Sovaldi also treat Hep C in HIV patients?
The results of a new clinical trial were excellent news for Gilead, but women and patients with cirrhosis were underrepresented in the study.
By Nicole Gray • July 21, 2014 -
Study: GSK's combo melanoma drug bests Roche's Zelboraf
Interim analysis shows improved overall survival rates in patients with metastatic melanoma -- one of the most serious forms of the cancer.
By Nicole Gray • July 21, 2014 -
Novartis profits rise on emerging markets, MS drug
Turnover is up 1% and net profits are up 3% compared with Q2 2013.
By Nicole Gray • July 18, 2014 -
Dicerna Pharmaceuticals moving to Cambridge, MA
The company, which had the largest biotech IPO in MA so far this year, is doubling its footprint and moving into a former Pfizer space.
By Nicole Gray • July 17, 2014 -
Abbott selling part of generics portfolio to Mylan
The transaction, which is valued at $5.3 billion, will close in Q1 2015
By Nicole Gray • July 15, 2014 -
Deep Dive
How pharma learned to stop worrying and love the tweet
Long-awaited FDA social media guidelines are providing much-needed direction.
By Nicole Gray • July 15, 2014 -
Suddenly, some cheap generics aren't so cheap
The increases have been so large that in some cases, insurance companies are requiring preapprovals for common prescriptions.
By Randy Lilleston • July 10, 2014 -
Deep Dive
Are investors feeling more love for pharma?
A recent survey counters long-standing perceptions that the industry is widely disliked.
By Nicole Gray • July 9, 2014 -
France recommends use of off-label Avastin for AMD
Lawmakers are focused on cost savings, but cite evidence-based efficacy and safety as justification.
By Nicole Gray • July 2, 2014 -
Pfizer's Elelyso becomes first kosher-certified prescription drug
The medication is used for long-term treatment of the disease.
By Randy Lilleston • July 2, 2014 -
GSK/Theravance apply for U.S. approval of once-daily asthma treatment
This two-drug, fixed-combo is designed to be used in various pulmonary conditions.
By Nicole Gray • July 1, 2014 -
MannKind gets major boost after FDA approves inhaled insulin
This approval is a long time coming and could have a major impact on compliance among diabetes patients.
By Nicole Gray • June 30, 2014 -
Janssen files for expanded use of Velcade in EU patients
The company wants to make the drug available for patients with mantle cell lymphoma.
By Nicole Gray • June 30, 2014 -
CHMP approves BMS' combo hep C therapy
The treatment is moving forward in Europe.
By Nicole Gray • June 30, 2014 -
Roche making $5 million milestone payment to Halozyme
The payment for the two companies' MabThera SC collaboration comes as the drug is launched in Europe.
By Nicole Gray • June 30, 2014 -
Eisai files NDA for lenvatinib in Japan
Thyroid cancer affects up to 29,000 people in Japan.
By Nicole Gray • June 27, 2014 -
FDA
FDA requests additional information on AstraZeneca's ovarian cancer drug
The agency has concerns related to efficacy and safety.
By Nicole Gray • June 26, 2014
Previous
